Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update

Vincerx Pharma, Inc. (NASDAQ:VINC) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 21,400 shares, an increase of 328.0% from the August 31st total of 5,000 shares. Based on an average daily trading volume, of 133,900 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 133,900 shares, the short-interest ratio is currently 0.2 days.

Vincerx Pharma Trading Up 1.8%

Shares of NASDAQ:VINC opened at $0.05 on Friday. The firm has a market cap of $266,410.60, a price-to-earnings ratio of 0.00 and a beta of 1.70. Vincerx Pharma has a 12-month low of $0.03 and a 12-month high of $15.20. The stock’s 50-day moving average price is $0.04 and its two-hundred day moving average price is $0.12.

Vincerx Pharma Company Profile

Vincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors.